Asper Oncogenetics is a set of genetic tests related to common and rare hereditary cancers, including colorectal cancer, breast and ovarian cancer, lung cancer, glioblastomas as well as cancer related syndromes.
We offer quick services for early diagnosis and estimation of disease risk. Early diagnosis of cancer is vital to improve the outcome of treatment and, therefore, prevent cancer related deaths.
Mainly sequencing-based approaches are in use, including next generation sequencing that allows reliable, relevant and accurate detection of disease related mutations and alterations in underlying genes. Moreover, APEX-based, MLPA-based tests etc have been implemented for special conditions.